are prone to attrition, which can result in inaccuracies in trend estimates. Moreover, survey data do not consistently contain dates relevant to identifying disease onset, such as the date of first diagnosis or the date of treatment.
Administrative health data that capture disease diagnosis information, such as hospital and physician service (i.e., billing) records are routinely collected and therefore often less expensive and timelier to use for prevalence and incidence trend estimation. 20 However, changes in data collection methods, coding and classification systems, and clinical and billing practices for chronic diseases can also affect the accuracy of longitudinal trend estimates. As well, the completeness of capture of administrative records for the entire population may change over time, which can result in selection biases. In Canada for example, Newfoundland and Labrador physician service records do not consistently capture patient information from physicians who do not bill on a feefor-service basis, which disproportionately affects the availability of diagnostic information for rural populations. 21 One of the routine uses of administrative health data in Canada is for chronic disease surveillance through the Canadian Chronic Disease Surveillance System (CCDSS). 22 The CCDSS 23 was created in 2009 to facilitate the collection and reporting of standardized, national estimates of diagnosed chronic disease prevalence, incidence, and health outcomes. It grew out of the National Diabetes Surveillance System (NDSS), which was established in 1999 as a collaborative network of provincial and territorial (P/T) diabetes surveillance systems and supported by Health Canada and then the Public Health Agency of Canada (PHAC). 24 In 2016, the CCDSS Data Quality Working Group was formed. 22 It conducts ad hoc data quality studies and examines data quality information that arises from a variety of sources, such as case definition validation studies and narrative reports about changes in data coding practices from P/T administrative staff. Trends in incidence and prevalence estimates may be used, in part, to assess data quality. 25 Longitudinal trends may be influenced by changes in data quality, in addition to true changes in population health. Unexpected or unexplained changes in trends can suggest opportunities for follow-up data quality investigations.
To date, there have been few, if any, studies that have tested whether trends in chronic disease incidence from the CCDSS are changing over time. The purpose of our study was to assess incidence trends for multiple chronic diseases at national and provincial/regional levels in the CCDSS and determine if these trends are best captured using a linear effect of time.
Methods

Data source
Data were obtained from the CCDSS online infobase for multiple fiscal years over the period from 1999 to 2012, this was the most recent data available at the time of analysis. 26 The infobase includes documentation on CCDSS methods, and the rules used to identify chronic disease cases within administrative databases. We focused on incident cases of disease because incidence is often not available from survey data and is a key measure of population disease risk. Incidence data were obtained for asthma (ages one year and older, 2000-2012), chronic obstructive pulmonary disease (COPD; ages 35 years and older, 2000-2012), diabetes (ages one year and older, 2000-2012), hypertension (ages 20 years and older, 1999-2012), ischemic heart disease (IHD; ages 20 years and older, 1999-2012), and stroke (ages 20 years and older, [2003] [2004] [2005] [2006] [2007] [2008] [2009] [2010] [2011] [2012] . The Data Quality Working Group selected these diseases because it was expected they would have trends of different shapes and directions; these diseases affect different body systems and are therefore less likely to move in concert. Data were obtained for the following regions: British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, Quebec, and Atlantic Canada (New Brunswick, Newfoundland, Nova Scotia, and Prince Edward Island). Data from Northern Canada were excluded due to low event rates and the practical challenges with modelling sparse cell sizes. Incidence counts were grouped by age group and sex. CCDSS data are publicly available by five-year or lifecourse age groups. For this analysis five-year age groups were used.
Statistical analysis
Incidence rates were calculated as the number of new disease cases in a year divided by the total population at risk as of the end of the fiscal year (i.e., March 31 st ) and expressed per 1000 population. Rates were age standardized using the 2011 Canadian Census population and then described using minimum and maximum values, as well as first year and final year values.
Crude incidence data were subsequently analyzed using multivariable negative binomial regression models. The number of incident disease cases in each year was the outcome. The natural logarithm of the total population for a province or region was the model offset. Model covariates were year, age group, and sex. Age group was included as a cubic covariate based on preliminary assessments of model fit.
This study proceeded in a series of steps to assess trends for each chronic disease and region. The regional data were also combined to assess the trend for Canada as a whole for each chronic disease.
First, a negative binomial model with year as a continuous linear covariate was fit to the data. Next, we applied a series of negative binomial models to the data where year was included as a restricted cubic spline with a truncated power basis. Restricted cubic splines (RCS), or natural splines, are constrained to be linear beyond the boundaries of the first and last knots. The splines are also constrained to have continuous first and second derivatives at each knot, that is, at each location where the piecewise polynomial functions join, 27 resulting in a flexible, smooth function. Fitting an RCS to the data allowed us to test for linearity without making any assumptions about the data's overall shape.
Three different RCS models were fit to the data: year as an RCS with five knots, year as an RCS with four knots, and year as an RCS with three knots. Using greater than five knots in an RCS is rarely needed to provide a good fit to the data; 28 less than three knots is equivalent to modelling the predictor as a cubic term in the model. Knots were placed at evenly spaced quantiles based on the recommendations by Harrell.
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The Akaike information criterion (AIC) 29 was used to assess which RCS model best fit the data. Once the best-fitting RCS model was identified, we used a likelihood ratio test to determine if the model with year as an RCS fit the data significantly better than the model with year as a linear effect. Statistical significance was assessed using a nominal α = 0.05.
Statistical analyses were performed using R software, version 3.4.3 (R Foundation for Statistical Computing, Vienna). The base functions and the Modern Applied Statistics with S (MASS) and Regression Modeling Strategies (rms) packages were used. Table 1 reports estimated age-standardized incidence rates per 1000 population for each chronic disease and region. These rates are provided for the first and final years of available data. In addition, the minimum and maximum estimates and their respective years are reported.
Results
For Canada, the first and final years of available estimates coincide with the highest and lowest values, respectively, for asthma, COPD, IHD, and stroke. Estimated age-standardized incidence rates for diabetes increased from 6.60 per 1000 population in 2000 to 7.60 per 1000 population in 2006 (first year of study observation period), then subsequently decreased to 6.17 per 1000 population in 2012, which was both the final year and lowest rate observed. Hypertension age-standardized incidence rates peaked at 32.81 per 1000 population in 2000, which was 0.93 per 1000 population greater than the first year Results from the likelihood ratio test for departures of year from a linear trend are reported in Table 3 . Overall, the results show that year departed from a linear trend in numerous regions for many diseases. Stroke incidence was most consistently linear over time, with only Manitoba departing from a linear trend (χ 2 = 17.2, df = 2, p < .001). In contrast, hypertension incidence was non-linear over time for every region except for Manitoba. For Canada, a non-linear incidence trend over time was evident for every disease, except for IHD (p = 0.692) and stroke (p = 0.964). Figure 1 reports the national age-standardized incidence rates for all diseases, illustrating the nature of the decreasing trend over time. Diabetes incidence generally increased before beginning to decrease in 2009. Inconsistent changes in incidence rates can be observed over time for diseases where the models with year as an RCS indicated that the national data did not have a linear effect of time (e.g., asthma, COPD, diabetes, and hypertension). For example, COPD incidence displays a mildly cubic shape and hypertension incidence has a slightly quadratic shape, where decreases in incidence rates are minimal at first and begin to increase as time progresses. In contrast, both IHD and stroke show little deviation from a linear trend, as indicated by the spline model results.
Discussion
Our study assessed Canadian chronic disease incidence rates over time and determined if the trends were best captured by modelling time (i.e., year) as a linear effect. Results from the models with a linear time effect showed that chronic disease incidence rates are slowly decreasing for all diseases except diabetes; however, in many cases, allowing for departures from linearity significantly improved model fit. Therefore, to fully understand the changing patterns of chronic disease incidence within and across Canada, researchers should consider using time as a non-linear factor to summarize and explain chronic disease incidence rates.
Previous Canadian studies [4] [5] [6] [7] [8] [9] 11, 12, [30] [31] [32] [33] about chronic disease incidence rates have described changes in incidence rates as absolute or relative differences between the first and last years of the study period, ignoring the rate patterns in the interim. Exceptions to this are two studies exploring the incidence rates of type one 15 and type two 16 diabetes in British Columbia. These studies analyzed the overall annual percent change in incidence rates and reported the years in which significant changes in rates occurred. Results from both studies indicate that changes in diabetes incidence rates were not constant over time and could not be fully described using the difference between the first and last years of observation. Based on our findings, incidence rates demonstrate an overall downward trend for all diseases except for diabetes. These findings are consistent with findings from other studies that have examined chronic Continued on the following page disease incidence rates within Canada using administrative health data. However, previous studies have not necessarily assessed incidence trends over the same period as was used in our study, so comparisons should be made with caution. 14 In Ontario, age-and sex-standardized concurrent asthma and COPD incidence rates decreased by 0.4 per 1000 from 2002 to 2012 and age-and sex-standardized COPD incidence rates decreased by 3.3 per 1000 from 1996 to 2007. 7, 8 Alberta age-and sex-standardized COPD incidence also decreased from 2002 to 2010, 10 and age-standardized incidence rates decreased by 5.1 per 1000 between 2001 and 2011 in Quebec. 9 Heart disease incidence rates (age-standardized) decreased in Quebec and Canada overall by approximately 5.6 per 1000 between 2000 and 2013, 12 [15] [16] [17] [18] Potential reasons for the overall decline in chronic disease incidence may include lower prevalence of modifiable risk factors 4 and improved prevention strategies. 34, 35 Differences in incidence patterns between regions could, in part, be due to differences across provinces in the strategies used to address chronic disease and risk factor management. 36 The decrease in hypertension, stroke, and IHD incidence for Canada is consistent with a decrease in mortality rates for cardiovascular-related diseases, including IHD, acute myocardial infarction, and heart failure. 13, 19 Other diseases, such as COPD, do not exhibit consistent trends in mortality rates, 19 suggesting disease treatment may also play a role in the relationship between incidence and mortality rates. For diseases with a shorter average time between detection and death, such as stroke, mortality rates may be more indicative of changing incidence rates, rather than changes in treatment.
CCDSS methods for using administrative data to capture disease incidence have been validated for several chronic diseases, including asthma, COPD, IHD, hypertension, and diabetes. [37] [38] [39] [40] [41] The first date of disease diagnosis is used in administrative data as a proxy for disease onset. Incidence trends captured by the CCDSS can provide valuable insights into changes in Canadian population health; however, they may be influenced by changes in administrative data quality, such as modifications in data collection methods, coding and classification systems, or billing practices. For example, an increase in the number of healthcare practitioners paid by salary who submit administrative data via shadow-billing rather than the traditional fee-for-service method may increase the number of missing diagnoses codes. 21 Changes in clinical practice and screening and diagnoses criteria also likely influence trends in chronic disease incidence captured by the CCDSS over time. incidence trends, where better healthcare access and continuity of care result in increased disease detection within the first years after program implementation. 42 Factors influencing administrative data and its collection should be considered when interpreting incidence rates obtained from the CCDSS.
There are several benefits to using CCDSS data to examine chronic disease incidence within Canada. Previous studies 4, [7] [8] [9] [10] [11] [12] [14] [15] [16] [17] [18] [31] [32] [33] 43 have only looked at diseases within one region of Canada. With CCDSS data, trends can be examined for Canada as a whole, as well as for different Canadian regions, using publicly available data. There is also good validity to compare the trends within different regions of Canada, as data were obtained using uniform case ascertainment methods. Moreover, CCDSS data can be used to assess longitudinal trends without interruption; national longitudinal survey data are often collected in waves with no available data for the years between waves.
While our analysis allowed us to determine if significant departures from linearity occurred for the time effect, it did not allow us to assess where the departures occurred. Such information would be beneficial to inform if, and how, specific changes in health policy (i.e., access to healthcare, physician reimbursement policies, billing practices), risk factors, and intervention efforts are related to disease incidence.
Future research could examine factors influencing changing incidence of chronic disease over time across Canada. Chronic disease incidence rates estimated from administrative data may be influenced by changes in population health status, clinical diagnostic and screening practices, or administrative practices within provinces, such as physician billing methods. Future analyses could focus on incidence estimates for other chronic diseases that are now a part of the CCDSS, including osteoporosis, depression, and osteoarthritis. The CCDSS Data Quality Working Group plans to explore incidence trends within Canada's P/Ts and conduct data quality surveys to help ascertain how much changing trends are due to changes in administrative practices or changes in population health.
